Urothelial Carcinoma Clinical Trials in Lake Success, New York

5 studies are recruiting for urothelial carcinoma in Lake Success, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

   The objective of this study is to evaluate the safety, tolerability, and efficacy of BL-M07D1 in patients with HER2 expressing advanced tumors.

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Start (Nyli), Lake Success, New York

   Locations

   26 in total

   Run by

   SystImmune Inc.

   See if you can join NCT06293898 on ClinicalTrials.gov

2. A Study of GEN1106 in Participants With Solid Tumors

   The purpose of this trial is to learn about the safety and effectiveness of GEN1106 when it is used for the treatment of participants with certain types of cancer. The trial has multiple parts. The first part of the trial tests different doses of GEN1106 to find out if it is safe and determine what…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   START New York Long Island LLC, Lake Success, New York

   Locations

   10 in total

   Run by

   Genmab

   See if you can join NCT07416123 on ClinicalTrials.gov

3. DBC-664 in Adult Patients With Solid Tumors

   DBC-664-ONC-101 is a first-in-human Phase 1a/1b open-label, multicenter study to evaluate the safety, tolerability, PK, pharmacodynamic, and preliminary anti-tumor activity of DBC-664 in patients with endometrial cancer, ovarian cancer, and other advanced solid tumors . This study is divided into 2…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   START New York, Lake Success, New York

   Locations

   5 in total

   Run by

   Duboce Biopharmaceuticals, Inc.

   See if you can join NCT07705035 on ClinicalTrials.gov

4. A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

   This study is being done to see if a drug called disitamab vedotin, alone or with pembrolizumab, works to treat HER2 expressing urothelial cancer. It will also test how safe the drug is for participants. Participants will have cancer that has spread in the body near where it started (locally advanc…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Northwell Health, Lake Success, New York

   Locations

   221 in total

   Run by

   Seagen, a wholly owned subsidiary of Pfizer

   See if you can join NCT04879329 on ClinicalTrials.gov

5. uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

   The purpose of this registry is to evaluate real world experience and outcomes of patients with Upper Tract Urothelial Cancer (UTUC) treated with Jelmyto in the United States.

   Stage

   Not phased

   Ages

   18 and older

   Site

   The Feinstein Institutes for Medical Research, Lake Success, New York

   Locations

   22 in total

   Run by

   UroGen Pharma Ltd.

   See if you can join NCT05874921 on ClinicalTrials.gov